Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 1.000 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.739 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.646 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.623 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.617 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.604 | |
| 2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.598 | |
| 3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.589 | |
| 2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.560 | |
| 2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.543 | |
| 3fi3 | JK2 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.536 | |
| 3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.534 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.530 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.525 | |
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.524 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.523 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.515 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.515 | |
| 4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.515 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.510 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.509 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.509 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.509 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.505 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.504 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.504 | |
| 4ux9 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.504 | |
| 5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.504 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.502 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.501 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.501 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.500 | |
| 3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.500 | |
| 4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.500 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.499 | |
| 1pmv | 537 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.498 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.497 | |
| 2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.497 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.497 | |
| 4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.496 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.496 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.495 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.495 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.494 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.494 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.492 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.491 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.491 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.490 | |
| 3flk | NAI | Tartrate dehydrogenase/decarboxylase | 1.1.1.93 | 0.490 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.490 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.490 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.489 | |
| 2xs0 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.488 | |
| 5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.488 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.488 | |
| 3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.487 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.487 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.487 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.487 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.485 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.485 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.485 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.485 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.484 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.483 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.483 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.482 | |
| 3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.482 | |
| 3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.482 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.482 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.482 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.481 | |
| 5dmz | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.481 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.480 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.480 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
| 2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.479 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.479 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.479 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.479 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
| 4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.479 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
| 4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.478 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.477 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.477 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.476 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.476 | |
| 3t14 | FAD | Sulfide-quinone reductase | / | 0.476 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.475 | |
| 1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.475 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.475 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.475 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.475 | |
| 1e3e | NAI | Alcohol dehydrogenase 4 | 1.1.1.1 | 0.474 | |
| 1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.474 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.473 | |
| 3sz0 | FAD | Sulfide-quinone reductase | / | 0.473 | |
| 4gj3 | 0XP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.473 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.472 | |
| 2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.472 | |
| 2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
| 2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.472 | |
| 3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.472 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.470 | |
| 2zdu | 446 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.470 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
| 4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.470 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.470 | |
| 4elf | 35I | Dihydrofolate reductase | / | 0.470 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.470 | |
| 3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.469 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.469 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.469 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.468 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.468 | |
| 3ori | AGS | Serine/threonine protein kinase | / | 0.468 | |
| 3t2z | FAD | Sulfide-quinone reductase | / | 0.468 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.468 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
| 2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.467 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.467 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.467 | |
| 3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.467 | |
| 4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.467 | |
| 4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.467 | |
| 4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.467 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.467 | |
| 4jnk | ZHK | L-lactate dehydrogenase A chain | 1.1.1.27 | 0.467 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
| 1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
| 1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.466 | |
| 2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.466 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.466 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.466 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.466 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.466 | |
| 3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.466 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.466 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.466 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.465 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.465 | |
| 3t2y | FAD | Sulfide-quinone reductase | / | 0.465 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.465 | |
| 4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.465 | |
| 1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.464 | |
| 3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.464 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 1d4a | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.463 | |
| 1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.463 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.463 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
| 3syi | FAD | Sulfide-quinone reductase | / | 0.463 | |
| 4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.463 | |
| 4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.463 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.463 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.463 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.462 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.462 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.462 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.462 | |
| 4ruo | BIV | Vitamin D3 receptor A | / | 0.462 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.462 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.461 | |
| 3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.461 | |
| 4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
| 5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.461 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.460 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
| 3orm | AGS | Serine/threonine protein kinase | / | 0.460 | |
| 4g7g | VFV | Lanosterol 14-alpha-demethylase | / | 0.460 | |
| 4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
| 4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.460 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
| 1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 1h69 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.459 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.459 | |
| 3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 3t2k | FAD | Sulfide-quinone reductase | / | 0.459 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.459 | |
| 3wfj | NAD | 2-dehydropantoate 2-reductase | / | 0.459 | |
| 5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.459 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.458 | |
| 2igo | FAD | Pyranose 2-oxidase | / | 0.458 | |
| 2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
| 4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.458 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.458 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.458 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.457 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.457 | |
| 3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.457 | |
| 4yry | FAD | Glutamate synthase, beta subunit | / | 0.457 | |
| 1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
| 1gg5 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.456 | |
| 1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.456 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 4wuo | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.456 | |
| 4yr9 | NAD | L-threonine 3-dehydrogenase, mitochondrial | 1.1.1.103 | 0.456 | |
| 5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
| 1h66 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.455 | |
| 1iyz | NDP | Probable quinone oxidoreductase | / | 0.455 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.455 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.455 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 3zux | TCH | Transporter | / | 0.455 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.455 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.455 | |
| 4qpm | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.455 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.455 | |
| 1bxo | PP7 | Penicillopepsin-1 | 3.4.23.20 | 0.454 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.454 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.454 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.454 | |
| 4dfr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
| 4elg | 52J | Dihydrofolate reductase | / | 0.454 | |
| 4l7f | 1V5 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.454 | |
| 1guf | NDP | Enoyl-[acyl-carrier-protein] reductase 1, mitochondrial | 1.3.1.10 | 0.453 | |
| 2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.453 | |
| 4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.453 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 4h8n | NDP | NADPH-dependent conjugated polyketone reductase C2 | / | 0.453 | |
| 4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.453 | |
| 4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
| 1dxq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.452 | |
| 1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.452 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.452 | |
| 1yb5 | NAP | Quinone oxidoreductase | 1.6.5.5 | 0.452 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
| 3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.452 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.452 | |
| 4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.452 | |
| 5a3b | APR | SIR2 family protein | / | 0.452 | |
| 1ie4 | T44 | Transthyretin | / | 0.451 | |
| 2cmj | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.451 | |
| 2d29 | FAD | Acyl-CoA dehydrogenase | / | 0.451 | |
| 2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.451 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.451 | |
| 2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.451 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.451 | |
| 3kpk | FAD | Sulfide-quinone reductase | / | 0.451 | |
| 3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.451 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.451 | |
| 3vt8 | YI3 | Vitamin D3 receptor | / | 0.451 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.451 | |
| 4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.451 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
| 4lfi | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
| 4o1p | ANP | Ribonuclease L | / | 0.451 | |
| 4utd | ACP | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.450 | |
| 2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.450 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.450 | |
| 4ele | 31I | Dihydrofolate reductase | / | 0.450 | |
| 4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.450 | |
| 4q71 | FAD | Bifunctional protein PutA | / | 0.450 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
| 2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
| 3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
| 3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 3t3c | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.449 | |
| 4uym | VOR | 14-alpha sterol demethylase Cyp51B | / | 0.449 | |
| 1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
| 1tdr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
| 2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.448 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.448 | |
| 3efw | AK8 | Aurora kinase A | 2.7.11.1 | 0.448 | |
| 3fco | IIG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.448 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.448 | |
| 4b8z | NAP | GDP-L-fucose synthase | 1.1.1.271 | 0.448 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.448 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
| 4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
| 4z63 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.448 | |
| 5dqr | FAD | 7-hydroxymethyl chlorophyll a reductase, chloroplastic | 1.17.7.2 | 0.448 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 2apg | FAD | Flavin-dependent tryptophan halogenase PrnA | 1.14.19.9 | 0.447 | |
| 2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
| 2pvm | P29 | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
| 2q5g | 1FA | Peroxisome proliferator-activated receptor delta | / | 0.447 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.447 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.447 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.447 | |
| 4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.447 | |
| 4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.447 | |
| 4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
| 4ryv | ZEA | Protein LlR18A | / | 0.447 | |
| 1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.446 | |
| 1zhw | HC2 | Oxysterol-binding protein homolog 4 | / | 0.446 | |
| 2qfx | NDP | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.446 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3uo5 | 0BX | Aurora kinase A | 2.7.11.1 | 0.446 | |
| 4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
| 4ki8 | ADP | 60 kDa chaperonin | / | 0.446 | |
| 4m87 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.446 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.446 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.446 | |
| 1dxo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.445 | |
| 1pnv | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.445 | |
| 1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.445 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
| 2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.445 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.445 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.445 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.445 | |
| 4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.445 | |
| 4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.445 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.445 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
| 5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.445 | |
| 5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.445 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.445 | |
| 1ppm | 0P1 | Penicillopepsin-1 | 3.4.23.20 | 0.444 | |
| 1q8y | ADP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.444 | |
| 1q97 | ATP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.444 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.444 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.444 | |
| 2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.444 | |
| 3sdi | 3SD | Proteasome subunit beta type-5 | 3.4.25.1 | 0.444 | |
| 3sdi | 3SD | Proteasome subunit beta type-6 | 3.4.25.1 | 0.444 | |
| 3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.444 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.444 | |
| 4ful | 0VU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.444 | |
| 4q73 | FAD | Bifunctional protein PutA | / | 0.444 | |
| 1jol | FFO | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 1w4z | NAP | Putative ketoacyl reductase | 1.3.1 | 0.443 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.443 | |
| 2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
| 3cxw | 7CP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3mqe | 416 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.443 | |
| 3slk | NDP | Polyketide synthase extender module 2 | / | 0.443 | |
| 3zc3 | NAP | Ferredoxin--NADP reductase | 1.18.1.2 | 0.443 | |
| 4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.443 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.443 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.443 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 5dn3 | ATP | Aurora kinase A | 2.7.11.1 | 0.443 | |
| 1hii | C20 | Gag-Pol polyprotein | / | 0.442 | |
| 1zp9 | ATP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.442 | |
| 2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
| 2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
| 3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
| 3nf4 | FAD | Acyl-CoA dehydrogenase domain-containing protein | / | 0.442 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
| 3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.442 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.442 | |
| 4a33 | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.442 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
| 4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
| 4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
| 4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
| 4ia2 | BIV | Vitamin D3 receptor A | / | 0.442 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 4uux | APR | CinA-like protein | / | 0.442 | |
| 1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.441 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.441 | |
| 2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3b6z | CO7 | Enoyl reductase LovC | 1 | 0.441 | |
| 3f46 | I2C | 5,10-methenyltetrahydromethanopterin hydrogenase | 1.12.98.2 | 0.441 | |
| 3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
| 3t11 | 3T1 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 3zpu | M8B | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 4a0m | NAD | Betaine aldehyde dehydrogenase, chloroplastic | 1.2.1.8 | 0.441 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
| 4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.441 | |
| 4g3e | 0WC | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.441 | |
| 4wx1 | FDA | UDP-galactopyranose mutase | / | 0.441 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.441 | |
| 5c03 | AGS | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.441 | |
| 1lp4 | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 1rv1 | IMZ | E3 ubiquitin-protein ligase Mdm2 | 6.3.2 | 0.440 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 2eba | FAD | Putative glutaryl-CoA dehydrogenase | / | 0.440 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 2w1e | L0E | Aurora kinase A | 2.7.11.1 | 0.440 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.440 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 | |
| 3qwb | NDP | Probable quinone oxidoreductase | 1.6.5.5 | 0.440 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.440 | |
| 4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
| 4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.440 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.440 | |
| 4eol | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 4hfm | NAP | 2-alkenal reductase (NADP(+)-dependent) | / | 0.440 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.440 | |
| 4lrj | ANP | Uncharacterized protein | / | 0.440 | |
| 4q72 | FAD | Bifunctional protein PutA | / | 0.440 | |
| 4u8k | FDA | UDP-galactopyranose mutase | / | 0.440 |